Literature DB >> 3231098

Shiga toxin: production and purification.

G T Keusch, A Donohue-Rolfe, M Jacewicz, A V Kane.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3231098     DOI： 10.1016/s0076-6879(88)65025-7

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  9 in total

1.  Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.

Authors:  A Donohue-Rolfe; D W Acheson; A V Kane; G T Keusch
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

2.  Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications.

Authors:  Abhineet S Sheoran; Susan Chapman-Bonofiglio; Barrett R Harvey; Jean Mukherjee; George Georgiou; Arthur Donohue-Rolfe; Saul Tzipori
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity.

Authors:  P R Austin; P E Jablonski; G A Bohach; A K Dunker; C J Hovde
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

4.  Physicochemical and biological properties of purified Escherichia coli Shiga-like toxin II variant.

Authors:  D L MacLeod; C L Gyles; A Valdivieso-Garcia; R C Clarke
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

5.  Expression and purification of Shiga-like toxin II B subunits.

Authors:  D W Acheson; S A De Breucker; M Jacewicz; L L Lincicome; A Donohue-Rolfe; A V Kane; G T Keusch
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems.

Authors:  D W Acheson; S B Calderwood; S A Boyko; L L Lincicome; A V Kane; A Donohue-Rolfe; G T Keusch
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

7.  Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants.

Authors:  Abhineet S Sheoran; Susan Chapman; Pradeep Singh; Arthur Donohue-Rolfe; Saul Tzipori
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

8.  Paromomycin and geneticin inhibit intracellular Cryptosporidium parvum without trafficking through the host cell cytoplasm: implications for drug delivery.

Authors:  J K Griffiths; R Balakrishnan; G Widmer; S Tzipori
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

9.  Mitomycin immunoblot colony assay for detection of Shiga-like toxin-producing Escherichia coli in fecal samples: comparison with DNA probes.

Authors:  A E Hull; D W Acheson; P Echeverria; A Donohue-Rolfe; G T Keusch
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.